Trimetazidine reduces early and long-term effects of experimental renal warm ischemia: A dose effect study

Journal of Vascular Surgery

Volumn 47, Issue 4, 2008, Pages

  Cau, Jerome ^a   Favreau, Frederic ^a   Tillement, Jean Paul ^b   Lerman, Lilach O ^c   Hauet, Thierry ^a,d   Goujon, Jean Michel ^a  

^a UNIVERSITÉ DE POITIERS   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c MAYO CLINIC   (United States)

^d CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRIMETAZIDINE; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DOSE RESPONSE; DRUG ACTIVATION; DRUG EFFICACY; EPITHELIUM CELL; FIBROSIS; HYPOXIA; INFLAMMATION; INFORMATION PROCESSING; KIDNEY EPITHELIUM; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE; MALE; MESENCHYME CELL; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SWINE; UNINEPHRECTOMY;

EID: 41249103576     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.10.036     Document Type: Article

References (42)

1. Ortiz A., Justo P., Sanz A., Lorz C., and Egido J. Targeting apoptosis in acute tubular injury. Biochem Pharmacol 66 (2003) 1589-1594
2. Bonventre J.V., and Weinberg J.M. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14 (2003) 2199-2210
3. Giulini S.M., Bonardelli S., Portolani N., Giovanetti M., Galvani G., Maffeis R., et al. Suprarenal aortic cross-clamping in elective abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 20 (2000) 286-289
4. Whalber E., Dimuzio P.J., and Stoney R.J. Aortic clamping during elective operations for infrarenal disease (The influence of clamping time on renal function). J Vasc Surg 36 (2002) 13-18
5. Sasaki T., Ohsawa S., Ogawa M., Mukaida M., Nakajima T., Komoda K., et al. Postoperative renal function after and abdominal aortic aneurysm repair requiring suprarenal aortic cross-clamp. Surg Today 30 (2000) 33-36
6. Siegel N.J., and Shah S.V. Acute renal failure: directions for the next decade. J Am Soc Nephrol 14 (2003) 2176-2177
7. Jassem W., Fuggle S.V., Rela M., Koo D.D., and Heaton N.D. The role of mitochondria in ischemia/reperfusion injury. Transplantation 73 (2002) 493-499
8. Li C., and Jackson R.M. Reactives species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physol 282 (2002) C227-C241
9. Hauet T., Goujon J.M., Baumert H., Petit I., Carretier M., Eugene M., et al. Polyethylene glycol reduces the inflammatory injury due to cold ischemia/reperfusion in autotransplanted pig kidneys. Kidney Int 62 (2002) 654-667
10. Hauet T., Goujon J.M., Vandewalle A., Baumert H., Lacoste L., Tillement J.P., et al. Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys. J Am Soc Nephrol 11 (2000) 138-148
11. Kantor P., Lucien A., Kozak R., and Lopaschuk G. The antianginal deug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 86 (2000) 580-588
12. El Banani H., Bernard M., Baetz D., Cabanes E., Cozzone K.B., Lucien A., et al. Changes in intracellular sodium and pH during ischemia-reperfusion are attenuated by trimetazidine. Comparison between low-and zero-flow ischemia. Cardiovasc Res 47 (2000) 688-696
13. Sentex E., Sergiel J.P., Lucien A., and Grynberg A. Trimetazidine increases phospholipid turnover in ventricular myocyte. Mol Cell Biochem 175 (1997) 153-162
14. Ruiz-Meana M., Garcia-Dorado D., Julia M., Gonzalez M.A., Inserte J., and Soler-Soler J. Pretreatment with trimetazidine increases sarcolemmal mechanical resistance in reoxygenated myocytes. Cardiovasc Res 32 (1996) 587-592
15. Morin D., Hauet T., Spedding M., and Tillement J. Mitochondria as target for anti-ischemic drugs. Adv Drug Deliv Res 49 (2001) 151-174
16. Argaud L., Gomez L., Gateau-Roesch O., Couture-Lepetit E., Loufouat J., Robert D., et al. Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury. J Mol Cell Cardiol 39 (2005) 893-899
17. Saikumar P., and Venkatachalam M.A. Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 23 (2003) 511-521
18. Jayle C., Favreau F., Zhang K., Doucet C., Goujon J.M., Hebrard W., et al. Comparison of protective effect of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model. Am J Physiol Renal Physiol 292 (2007) 1082-1093
19. Zahedi K., Wang Z., Barone S., Tehrani K., Yokota N., Petrovic S., et al. Identification of stathmin as a novel marker of cell proliferation in the recovery phase of acute ischemic renal failure. Am J Physiol Cell Physiol 286 (2004) C1203-C1211
20. Yancey P.H. Organic osmolytes as compatible, metabolic and counteracting cyto- protectants in high osmolarity and other stresses. J Exp Biol 208 (2005) 2819-2830
21. Kunduzova O.R., Escourrou G., De La Farge F., Salvayre R., Séguélas M.H., Leducq N., et al. Involvement of peripheral benzodiazepine receptor in the oxidative stress, death-signaling pathways, and renal injury induced by ischemia-reperfusion. J Am Soc Nephrol 15 (2004) 2152-2160
22. Goujon J.M., Hauet T., Menet E., Levillain P., Babin P., and Carretier M. Histological evaluation of proximal tubule cell injury in isolated perfused pig kidneys exposed to cold ischemia. J Surg Res 82 (1999) 228-233
23. Junqueira L., Bignoles G., and Brentani R. Picro Sirius staining plus polarization microscopic, a specific method for collagen detection in tissue sections. Histochem J 11 (1979) 447-455
24. Morin D., Sapena R., Elimadi A., Testa B., Labidalle S., Le Ridant A., et al. (3)H-trimetazidine mitochondrial binding sites: regulation by cations, effect of trimetazidine derivatives and other agents and interaction with an endogenous substance. Br J Pharmacol 130 (2000) 655-663
25. Serkova N., Florian Fuller T., Klawitter J., Freise C.E., and Niemann C.U. 1H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion in rat kidney transplants. Kidney Int 67 (2005) 1142-1151
26. Saikumar P., and Venkatachalam M.A. Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 23 (2003) 511-521
27. Yin R.X., Liang W.W., Liu T.W., Tao X.Z., Zhu L.G., and Al-Ghazali R. Inhibitory effect of trimetazidine on cardiac myocyte apoptosis in rabbit model of ischemia-reperfusion. Chin Med Sci J 19 (2004) 242
28. Morin D., Elimadi A., Sapena R., Crevat A., Carrupt P.A., Testa B., et al. Evidence for the existence of [3H]-trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition pore. Br J Pharmacol 123 (1998) 1385-1394
29. Basile D.P., Donohoe D.L., Roethe K., and Mattson D.L. Chronic renal hypoxia after acute ischemic injury: effects of L-ariginine on hypoxia and secondary damage. Am J Physiol Renal Physiol 284 (2003) F338-F348
30. Eckardt K.U., Bernhardt W.M., Weidmann A., Warnecke C., Rosenberger C., Wiesener M.S., et al. Role of hypoxia in the pathogenesis of renal disease. Kidney Int 68 (2005) S46-S51
31. Villanueva S., Cespedes, and Vio C.P. Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol 290 (2006) 861-870
32. Haase V.H. Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 291 (2006) F271-F281
33. Vongwiwatana A., Tasanarong A., Rayner D.C., Melk A., and Halloran P.F. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cell in fibrogenesis. Am J Transplant 5 (2006) 1367-1374
34. Ceradini D.J., and Gurtner G.C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 15 (2005) 57-63
35. Gueler F., Gwinner W., Schwarz W., and Haller L. Long-term effects of acute ischemia and reperfusion injury. Kidney Int 66 (2004) 523-527
36. Heinzelmann M., Mercer-Jones M.A., and Passmore J.C. Neutrophils and renal failure. Am J Kidney Dis 34 (1999) 384-399
37. Burne-Taney M.J., and Rabb H. The role of adhesion molecules and T cells in ischemic renal injury. Curr Opin Nephrol Hypertens 12 (2003) 86-90
38. Bonventre J.V., and Zuk A. Ischemic acute renal failure: an inflammatory disease?. Kidney Int 66 (2004) 480-485
39. Ysebaert D.K., De Greef K.E., De Beuf A., Van Rompay A.R., Vercauteren S., Persy V.P., et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 66 (2004) 491-496
40. Burne-Taney M.J., Yokota N., and Rabb H. Persistent renal and extrarenal immune changes after severe ischemic injury. Kidney Int 67 (2005) 1001-1009
41. Kaur H., Padi S.S., and Chopra K. Attenuation of renal ischemia-reperfusion injury by trimetazidine: evidence of an in vivo antioxidant effect. Meth Find Exp Clin Pharmacol 25 (2003) 803-809
42. Singh D., and Chopra K. Effect of trimetazidine on renal ischemia/reperfusion injury in rats. Pharmacol Res 50 (2004) 623-629